Editas Medicine (EDIT) P/FCF US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
P/FCF | -31.6 | -22.0 | -10.5 | -3.36 | -5.62 | -3.03 | |||
Changes by years, y/y, % | +49% | -30% | -52% | -68% | +67% | -23.3% |
Editas Medicine. P/FCF
Editas Medicine. P/FCF, changes, %
Editas Medicine (EDIT) P/FCF US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
P/FCF | -4.08 | -6.05 | -4.03 | -2.24 | -1.47 | -3.03 | ||
Changes by years, y/y, % | -15% | +80% | +35% | -35% | -64% | |||
Changes by quarters, q/q, % | +17% | +48% | -33% | -44% | -34% |